Social media

Reporting results with clarity and consistency Decision makers require accessible, reproducible outputs. The whitepaper explains how evidence networks, forest plots, league tables and rankograms work together to communi...

Reporting results with clarity and consistency Decision makers require accessible, reproducible outputs. The whitepaper explains how evidence networks, forest plots, league tables and rankograms work together to communi...

Parkinson’s disease (PD) is the fastest-growing neurological condition in the world, and recent estimates suggest that the number of people living with Parkinson’s will double to 25 million by the year 2050. Explore how ...

ICON is excited to sponsor RAPS Euro Convergence 2026, taking place 5–8 May in Lisbon. ICON are joining regulatory leaders at RAPS Euro Convergence 2026, taking place 5–8 May in Lisbon. Drop by and meet Gabriel Bohl a...

ICON is excited to sponsor RAPS Euro Convergence 2026, taking place 5–8 May in Lisbon. ICON are joining regulatory leaders at RAPS Euro Convergence 2026, taking place 5–8 May in Lisbon. Drop by and meet Gabriel Bohl a...

Pediatric trials face unique complexity but selecting a fit for purpose HRQoL measure doesn’t have to. The FDA’s PFDD Guidance emphasizes that historical use is not justification. Sponsors must demonstrate why an instrum...

Pediatric trials face unique complexity but selecting a fit for purpose HRQoL measure doesn’t have to. The FDA’s PFDD Guidance emphasizes that historical use is not justification. Sponsors must demonstrate why an instrum...

Join us on 6 May at OCT Europe in Barcelona. At 12:00pm in Stream C, Ankita Minhas will present “The global biotech sector: A CRO perspective”. Discover how rising scientific and operational complexity, AI‑driven innovat...

Join us on 6 May at OCT Europe in Barcelona. At 12:00pm in Stream C, Ankita Minhas will present “The global biotech sector: A CRO perspective”. Discover how rising scientific and operational complexity, AI‑driven innovat...

ICON Biotech will participate in #CTOWC26, the 13th Annual Clinical Trials in Oncology West Coast, taking place on 28–29 April 2026 in Burlingame, California. The event brings together oncology and clinical research pr...

ICON Biotech will participate in #CTOWC26, the 13th Annual Clinical Trials in Oncology West Coast, taking place on 28–29 April 2026 in Burlingame, California. The event brings together oncology and clinical research pr...

We’re honoured to be recognised for the second consecutive year at the Asia‑Pacific Biopharma Excellence Awards 2026, winning Best Clinical Trial Supplier: Site Innovation. This award reflects the dedication of our APAC...